PFS Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$273K Buy
10,799
+1,512
+16% +$38.2K ﹤0.01% 454
2023
Q1
$316K Buy
+9,287
New +$316K 0.01% 425